Analyst Ratings for Opus Genetics (IRD)
IRD Rating Summary
IRD Price Target Summary
- Highest: $16.00 (Guggenheim)
- Lowest: $7.00 (Piper Sandler)
- Average: $10.19
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$10.19 (+166%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/29/2026 | TD Cowen » Updated 8/19/2026 |
Ritu Baral | New Coverage | Buy (N/A) |
N/A (N/A) |
3.41 (3.83) |
12.32% | Details |
| 6/23/2026 | RBC Capital » Updated 8/7/2026 |
Lisa Walter | New Coverage | Outperform (N/A) |
9.00 (10.00) |
4.08 (3.83) |
-6.13% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
